slow progressors (PSPs) typically have viral loads of ∼30,000 HIV copies/ml and generally do not express HLA class I molecules that are protective against adult disease progres sion (Adland et al., 2015; Muenchhoff et al., 2016) . These children thus share some features of nonpathogenic SIV in fection observed in natural nonhuman primate hosts such as the sooty mangabey, that is characterized by preservation of normal peripheral CD4 counts in the face of persistently high viral loads (ReyCuillé et al., 1998) . In addition, the localiza tion of the virus predominantly in the shortlived memory CD4 + T cells is a second aspect of immunodeficiency virus infection that is shared by HIVinfected pediatric nonpro gressors and SIVinfected sooty mangabeys (Paiardini et al., 2011; Muenchhoff et al., 2016) . In combination with the tolerogenic immune environment in early life that limits the establishment of the viral reservoir, these features together suggest a greater potential for HIV cure in children than adults .
To further investigate HIV cure potential among PSPs, defined here as perinatally infected children who did not meet prevailing clinical (World Health Organization [WHO] stage III/IV clinical disease) or CD4 (maintained CD4 >350 cells/ mm 3 ) criteria for ART initiation by the age of 5 yr, we stud ied HIVspecific CD8 + T cell activity among these children, because, according to "shockandkill" strategies proposed (Deeks, 2012) , these cells would play a critical role in clearance of HIVinfected cells after latency reversal in ARTtreated in dividuals (Deng et al., 2015; Jones and Walker, 2016; Margo lis et al., 2016) . We hypothesized that the nature of the viral reservoir may differ between children and adults , in that multiple escape mutants are rapidly selected early in the course of adult infection, and these escape viruses constitute the major part of the adult viral reservoir (Deng et al., 2015) . In contrast, although HIVspecific CD8 + T cell responses are detectable early in life, viral setpoint is not es tablished in infected children until 5 yr of age, even in those maintaining normalforage CD4 counts . Furthermore, studies of early pediatric progression have failed to demonstrate the selection of escape mutants, even when there are detectable CTL responses restricted by HLA alleles that are "protective" in adult infection, such as HLAB*57/58:01/81:01 (Adland et al., 2015) . This prompts the hypothesis that HIVspecific CD8 + T cells do not impose significant selection pressure on HIV in early life sufficient for the widespread selection of escape mutants and, therefore, that viral reservoirs in infected children on ART are popu lated largely by wildtype virus. However, studies of CD8 + T cell escape have not been undertaken to date in PSPs, with access to maternal samples and longitudinal pediatric sam ples in combination with nextgeneration sequencing, that together allow this issue to be interrogated.
To examine the impact of HIVspecific CD8 + T cell responses on circulating virus in PSPs, we determined the HIVspecific CD8 + T cell responses and ultradeep sequenced virus within longitudinal samples from 11 PSPs from a histor ical cohort of perinatally infected children and their mothers followed from birth through the first decade of life, recruited in 2003-2005 to the Pediatric Early HAA RT and Strate gic Treatment Interruption Study Prendergast et al., 2008) . We hypothesized, based on previ ous studies in adults , that the breadth, specificity and function, reflected by the selection of virus escape mutants, of HIVspecific CD8 + T cell responses would differ according to viral load in the PSPs. We report here that two distinct HIVspecific CD8 + T cell immune strategies can be discerned among PSPs: one is similar to that adopted by adult elite controllers and viremic controllers (VCs), and the other is reminiscent of that described among adult viremic noncontrollers (VNCs; Kiepiela et al., 2007) .
resuLts

PsPs categorized into high-and low-viremic groups
Of 75 perinatally infected South African infants followed lon gitudinally from birth , before universal ART recommendation for pediat ric HIV infection, 11 children had failed to meet prevailing clinical (WHO stage III/IV clinical disease) or CD4 criteria (absolute CD4 count of <350 cells/mm 3 ) for ART initiation by 5 yr of age. These children we define here as PSPs (Table 1) .
Hypothesizing that, as in adults, the HIVspecific CD8 + T cell responses might differ with respect to specificity, breadth, and function, PSPs were subdivided into two subgroups ac cording to the median viral load: one with persistently higher and one with persistently lower viral loads ( Fig. 1 A) . These we have termed VCs and VNCs. Although the viral loads overall were 0.87 log 10 lower in the VNC group (P = 5 × 10 −14 ), there was no significant difference between the groups in either absolute CD4 count or CD4% (Fig. 1, B and C), which remained healthy (median 735 cells/mm 3 and 29.5%) and very similar in both groups, after the natural CD4 and CD4% decline over the first 5 yr that is observed in healthy uninfected children (Shearer et al., 2003; Lugada et al., 2004) .
Broad, high-magnitude non-Gag-specific cd8 responses among Vnc PsPs in early life
Specificity and breadth of the HIVspecific CD8 + T cell re sponse has been related to viral load in previous studies of adult HIV infection, with broad Gagspecific responses asso ciated with lower viral loads, and broad Env, Nef and ac cessoryregulatory protein (Vif/Vpr/Vpu/Tat/Rev)-specific responses associated with higher viral loads (Klein et al., 1995; Riviére et al., 1995; Ogg et al., 1998; Barouch et al., 2002 Barouch et al., , 2003 Edwards et al., 2002; Novitsky et al., 2003; Masem ola et al., 2004; Zuñiga et al., 2006; Geldmacher et al., 2007; Kiepiela et al., 2007; Streeck et al., 2007; Janes et al., 2013) . We therefore next investigated whether differential CD8 + T cell activity might explain the distinct viral loads among the two groups of PSPs. Using a panel of 410 overlapping 18mer peptides spanning the clade C proteome, we deter mined in IFNγ ELI SPOT assays which individual peptides were recognized (Addo et al., 2003; Kiepiela et al., 2004) . In both groups, HIVspecific CD8 + T cell responses signifi cantly increased with age in breadth and magnitude (Fig. 2, A and B) . However, total breadth was 1.5 responses higher in VNC than in VC PSPs (P = 3 × 10 −9 ; Fig. 2 A) . This dif ference in breadth was most significant in Nef, AccReg, and Envspecific responses (P = 4 × 10 −10 , 4 × 10 −5 , and 4 × 10 −4 , respectively), but not in Gag (P = 0.07; Fig. 2 A) . A similar pattern was observed for the magnitude of CD8 + T cell responses (Fig. 2 B) . Overall, breadth and magnitude of non-Gag/Polspecific responses were higher than breadth and magnitude of Gag/Polspecific responses in the VNC children, whereas the reverse pattern was observed in the VC children ( Fig. 3) . These pediatric data are therefore consis tent with adult studies indicating increased viral loads asso ciated with non-Gagspecific responses, particularly those directed toward Env or Nef.
selection pressure in Vc and Vnc children targeting Gag-tL9
To investigate the impact on the virus of HIVspecific CD8 + T cells in these two distinct groups of PSPs, we next tracked the HIVspecific CD8 + T cell responses and ki netics of selection pressure imposed on HIV from birth through childhood in each child also having access to sam ples from the transmitting mother. To maximize the reso lution of adaptive sequence changes, we deep sequenced the virus. Phylogenetic analysis of fulllength consensus sequences for all 11 mother-child pairs confirmed the close relationship between virus in each mother-child pair (Fig. S1) . In each child, we analyzed the regions of the virus encoding the CD8 + T cell epitopes restricted by any of the six HLA alleles expressed by that child using a panel of wellcharacterized epitopes (Goulder et al., 1997 (Goulder et al., , 2000 (Goulder et al., , 2001a Honeyborne et al., 2006; Matthews et al., 2008 Matthews et al., , 2011 Matthews et al., , 2012 Ngumbela et al., 2008; Kløverpris et al., 2012a Kløverpris et al., ,b, 2013 Kløverpris et al., , 2014a Llano et al., 2013) representing all the HIV proteins (see Materials and methods). For this analysis, variants shared with the mother expressing the same HLA class I molecule as the child were presumed to have been transmitted and not to have arisen de novo in the child. If the variant arose after the initial time point in the child, it was assumed that this variant was selected in the child and was not transmitted.
We first focused on the specific CD8 + T cell responses and viral sequence changes in three children, all of whom targeted the same immunodominant GagTL9 epitope (TPQ DLN TML, Gag residues 180-188). These three pediat ric subjects comprised one VC child, 133C, and two VNC children, 517C and 021C.
The VC slow progressor 133C made a dominant HLA B*81:01-restricted response from the first time point tested (Figs. 4, A-C). The virus transmitted to this child encoded the wildtype TL9 epitope, and a T186M variant was selected that had almost reached fixation (96% frequency) by 2.7 yr of age ( Fig. 4 D) . Population sequencing showed that the T186M mutant arose between 0.7 and 1.3 yr (Thobakgale et al., 2009) . A T186M variant-specific CD8 + T cell response was detectable by 1.3 yr of age and ultimately dominated the TL9specific response ( Fig. 4 E) . The more common Figure 1 . slow-progressor children categorized according to viremia into Vc and Vnc groups. (A) Viral loads for the 11 PSPs in the first decade of life for all time points off ART. (B and C) Absolute CD4 counts and CD4% for the 11 PSPs for all time points off ART. Each individual is shown in a unique symbol and linking line, colored according to VC (blue) or VNC (red) grouping. An estimate of best fit (LOW ESS lines) is shown for each PSP group in a thick solid line and the corresponding 95% confidence interval is denoted by the blue or red shaded area. Likelihood-ratio test p-values are from linear mixed-effects modeling comparing PSP groups and take into account all time points. HLAB*81:01associated T186S mutation has previously been shown to substantially reduce viral replicative capacity (VRC; Wright et al., 2010) , and analyses here of the T186M mutant demonstrated the same result ( Fig. 4 F) . Thus, the VC child 133C achieved successful control of HIV (viral load of 520 copies/ml when leaving the study to relocate at 9 yr of age) via (1) an early, strong GagTL9-specific response driving the selection of an escape mutant that abolished viral growth, at least in vitro; and (2) the generation of a strong TL9T186M variant-specific response.
In addition to the GagTL9-mediated selection pres sure on the virus during the first months of life in 133 C, there was also evidence of broad, CD8 + T cell-driven escape selection (Table 2) , including within Gag. The epi tope GagSK10 (SIL RGG KLDK, Gag residues 6-15) is re stricted by HLAA*74:01 (Matthews et al., 2011) , an allele not shared with the mother 133M. In previous studies of C clade-infected adults, the characteristic HLAA*74:01associated escape mutant is Gag K12N (at P7 in the epitope); the association between selection of K12N and expression of HLAA*74:01 carries a q value of 6 × 10 −17 (Carlson et al., 2014) . The virus transmitted by the HLAA*74:01negative mother, as expected, encoded the wildtype HLA A*74:01GagSK10 epitope, and K12N was selected in 100% of sequences in the HLAA*74:01-positive child by 3.6 mo of age. Similarly, in two HLAB*81:01-restricted epitopes (HLAB*81:01 was also not expressed in the mother 133M), in PolSL10 (SPI ETV PVKL, Pol residues 158-167) and NefRM9 (RPQ VPL RPM, Nef residues 71-79), 100% of transmitted sequences encoded wildtype epitopes, yet escape mutations were selected in 133C by 3.6 mo of age. These data demonstrate that CD8 + T cell responses in the VC slow progressor 133C exerted selec tion pressure on the virus within the first months of life in Gag and nonGag epitopes. In addition, variantspecific GagTL9 responses were generated, likely in the first year of life, effectively negating the benefit to the virus of the original escape mutant.
In both VNC slow progressors, 517C and 021C, the GagTL9 responses were restricted by HLAB*42:01 as op posed to HLAB*81:01, arose later in the course of infection (Fig. 5 ), and did not become immunodominant for several years. In 517C, the dominant response initially was to the HLAC*03-restricted GagYL9 epitope (YVD RFF KTL, Gag 286-304). Early Gag escape mutants were not observed in 517C, and no GagTL9 escape mutants were observed at any time point studied through 8.5 yr ( Fig. 5 D and Tables 3, S1, and S2). However, a broad array of nonGag escape mu tants were selected to fixation within 2.4 mo of birth (517C was infected intrapartum and only became viremic at 28 d), for example within the HLAB*15:10-restricted Rev epitope IL9 (IHS ISE RIL, Rev residues 52-60; Table 3 ). HLAB*15:10 was not expressed in the mother 517M and, as expected, the maternal virus transmitted encoded the wildtype RevIL9 epitope. Other epitopes in which escape to fixation appeared to have occurred by 2.4 mo of age in 517C were in two HLAB*42:01-restricted Env epitopes, RI10 (RPN NNT RKSI, Env residues 298-307) and IF9 (IPR RIR QGF, Env residues 843-851), and in two HLAA*30:02-restricted Env epitopes, KY9 (KYL GSL VQY, Env residues 794-802) and IY9 (IVN RVR QGY, Env residues 704-712). In all four cases, the epitope mutant in the child's viral population differed in 100% of viral sequences from the maternal sequence. The ca veat here would be that both mother and child express HLA A*30:02 and HLAB*42:01 and that the samples sequenced were of plasma virus 2-3 mo after transmission. However, particularly in view of the clearcut evidence of early escape within the HLAB*15:10 Rev IL9 epitope, it would seem very likely that early escape is driven to fixation in these four Env epitopes, with additional evidence of early escape in al most 50% of sequences within the HLAA*30:02-restricted Pol epitope AY9 (AQN PEI VIY, Pol residues 328-366) and in 60% of sequences within the HLAB*15:10-restricted Vif epitope WI9 (WHL GHG VSI, Vif residues 79-87; Table 3 ).
In the other VNC child, 021C, escape in the GagTL9 epitope was observed, but only relatively late, with no epi tope variants being evident at 2.6 yr ( Fig. 5 H) . Again, early escape within 2 mo of birth was evident in nonGag epi topes. HLAA*29:02 was not expressed in the mother (Table  S2 ). This lowfrequency variant was ultimately replaced by the characteristic HLAA*29:02 escape footprint in this epi tope (Carlson et al., 2012) . Another instance of early escape within 2 mo of birth was evident again at low frequency within the HLAA*02-restricted PolVL9 (VIY QYM DDL, Pol residues 334-342). HLAA*02 was not shared with the mother (Table S2 ). However, this variant did not persist and reverted back to wildtype in 100% sequences. There were no other instances of early escape identified in this child's viral sequences, although many escape mutants were trans mitted, and in this mother-child pair, five of the six HLA class I molecules were shared.
Thus, in the VC child 133C, there was evidence of strong selection pressure within the first 3 mo of life, with broad Gagspecific CD8 + T cell responses generated (to HLAA*74GagSK10 and HLAB*81GagTL9) and es cape mutants within Gag, Pol, and Nef, all reaching fixation The magnitude of differences between five VC and six VNC children is shown in black text, and estimates of annual change shown in blue and red text, respectively. RTV VV, Rev/Tat/Vif/Vpu/Vpr/Tat/Rev. An estimate of best fit (LOW ESS lines) is shown for each PSP group in a thick solid line, and the corresponding 95% confidence interval is denoted by the blue or red shaded area. P-values were determined by linear mixed-effects modeling that take into account all time points. Each ELI SPOT measurement is the sum of two to three technical replicates, depending on cell availability. in that time. In contrast, although escape mutants were se lected within the same time period in the two VNC children (517C and 021C), these were mostly in Env, and none were in Gag. These data are consistent with the notion of control of broad Gagspecific CD8 + T cell responses contributing to lower viremia in early pediatric infection, as previously shown in adult infection (Klein et al., 1995; Riviére et al., 1995; Ogg et al., 1998; Edwards et al., 2002; Novitsky et al., 2003; Mase mola et al., 2004; Zuñiga et al., 2006; Geldmacher et al., 2007; Kiepiela et al., 2007; Streeck et al., 2007) .
Preferential recognition of autologous Gag-tL9 variant in children, but not adults
The observation that preferential recognition of the autol ogous variant is more common in HIVinfected children than adults was previously made with respect to the HLA B*57/58:01-restricted GagTW10 epitope . To investigate whether this might apply more gen erally, we here investigated whether preferential recognition of the autologous GagTL9 variant is also observed more commonly in pediatric than adult infection. We identified 11 Magnitude of differences between five VC and six VNC children is as shown on each panel, in black text. Magnitude of differences between Gag/Pol and Nef/Env/Acc/Reg targeted responses is shown in red (VNC) or blue (VC) bold text. An estimate of best fit (LOW ESS lines) is shown for each PSP group and antigen group in a thick solid line (Gag/Pol) or thick dotted line (Nef/Env/Acc/Reg). Corresponding 95% confidence intervals for best fit lines are denoted by the blue or red shaded areas. For each of the 11 individuals the sum of the breadth, or magnitude of responses to the combination of antigens (Gag/Pol or Nef/Env/Acc/Reg) was calculated at each time point, and p-values were determined by linear mixed-effects modeling that take into account all time points. SFC, spot-forming cell.
children and 16 adults from Southern Africa infected with C clade virus who expressed either HLAB*42:01 and/or HLA B*81:01 and in whom autologous virus encoded a GagTL9 variant (Table S3 ). In two of the HIVinfected children, pop ulation sequencing of autologous virus initially demonstrated the presence of a mixture of variants at GagTL9 variants at Gag182 (position 3 in the epitope; Fig. 6 , A and B), sug gesting recent selection of escape (Goonetilleke et al., 2009) . Preferential recognition of the single autologous GagTL9 variant that subsequently emerged was demonstrated in both of these two children (Fig. 6, A and B ). Overall, in the 11 children studied, preferential recognition of the autolo gous GagTL9 variant was observed in all but one (91%), whereas in the 16 adults studied, preferential recognition of the autologous variant was observed in only 5 (31%; P = 0.0047; Fig. 6 , C and D).
The caveats here (discussed further below) are that the transmitted virus in all of the adults and some of the children were unknown. However, in 3 of the children, an evolving preferential recognition of the autologous GagTL9 variant was demonstrated (Figs. 4 and 6) , and in 4 more children, ma ternal virus encoded wildtype GagTL9 and/or the mother was HLAB*42:01/81:01 negative. Even if one restricts the analysis to these 7 children, the observed preferential recog nition of autologous GagTL9 variants remains significantly greater in children than adults (P = 0.0045, Fisher's exact test).
contrasting selection pressure in Vc and Vnc children
To examine selection pressure more broadly and compare the differences between VNC and VC children in the kinetics of accumulation of escape mutants, we calculated the proportion of epitopes within the most immunogenic proteins (Gag, Pol, Nef, and Env) restricted by the HLA alleles expressed in each subject that contained at least one nonsynonymous mutation for each time point. The rates of escape accumulation were cal culated by linear regression modeling, and the statistical uncer tainty of these rates was assessed by generating 50 bootstrapped datasets for each patient. This revealed that there was signifi cantly greater selection for HLAassociated escape in Env and Nef and less selection for escape in Pol in the VNC group com pared with VC children (Fig. 7, A and B ). Gagspecific escape did not differ significantly between the two groups. The in terquartile range (IQR) of the difference in the rate of escape between VNC and VC children (calculated by bootstrapping viral sequence data from each subject) was estimated in order to assess the statistical robustness of these patterns (Fig. 7 C) . These analyses confirm the robustness of the specificity differences of CD8 + T cell selection pressure observed in favor of Nef and Env among VNC children and in favor of Pol among VC children.
Collectively, these data indicate that CD8 + T cells among the slowprogressor children studied exert HLAassociated pressure on the virus from the very first weeks of infection, with unequivocal evidence of escape selection within the first months of life and escape mutants accumulating with age. The patterns of CD8 + T cell activity in the PSPs differ such that in the VNC group, CD8 + T cells preferentially target nonGag/ Pol epitopes and exert greater HLAassociated selection pres sure in Nef/Env epitopes and vice versa in the VC children. These distinct patterns of CD8 + T cell activity, together with the observed differences in viral loads in the VC and VNC groups, are consistent with previous studies linking nonGag/ Pol specificity of CD8 + T cell responses with high viremia (Klein et al., 1995; Riviére et al., 1995; Ogg et al., 1998; Ba rouch et al., 2002 Ba rouch et al., , 2003 Edwards et al., 2002; Novitsky et al., 2003; Masemola et al., 2004; Zuñiga et al., 2006; Geldmacher et al., 2007; Kiepiela et al., 2007; Streeck et al., 2007; Janes et al., 2013) , as discussed further below.
dIscussIon
In this study, we sought to investigate the potential for HIVspecific CD8 + T lymphocyte activity to play an effective role in viral eradication of pediatric HIV infection, because CD8 + T cells play a key role in shockandkill HIV cure strat egies (Deeks, 2012) , and because previous studies have indi cated that the potential for HIV cure may be higher among infected children than adults . Studying ARTnaive PSPs followed through childhood, we hypoth esized that the breadth, specificity, and function (reflected by the selection of CTL escape mutants) of HIVspecific CD8 + T cells would differ according to viremia. We divided these children into low and viremia groups (termed VCs and VNCs, respectively) that did not differ significantly by abso lute CD4 count or CD4%. The HIVspecific CD8 + T cell responses in VCs were of lower breadth and magnitude than those of VNCs but focused predominantly on Gag and Pol specificities compared with Nef and other accessory/regu latory proteins (Nef/AccReg) and Env, whereas the reverse applied among VNCs. Unexpectedly, in both groups, escape mutations were selected from early infancy; however, in VCs, the selection pressure on the virus focused more on Gag/Pol than on Nef/AccReg/Env, and the reverse was the case in VNCs. Finally, preferential recognition of autologous epitope variants in children, but not adults, was shown with respect to GagTL9, the immunodominant epitope for approximately one third of HIVinfected individuals in subSaharan Africa, also demonstrating the potential for HIVspecific CTL in children to corner the virus.
This escapecornering strategy has long been proposed as a theoretical immune tactic against HIV (O'Connor et al., 2001; Altfeld and Allen, 2006 ; Allen and Altfeld, 2008) and has been mathematically modeled (Ferguson et al., 2013) . That such a strategy can be effective is demonstrated for the first time here. In the current study, we observe the HLA B*81:01 TL9Gag response first drives the selection of an es cape variant such as T186M, which substantially reduces viral replicative capacity (Fig. 4) ; then, by the generation of a vari antspecific CTL response, the virus is down an evolutionary culdesac with apparently no further viable escape options. These findings suggest the potential for HIVspecific CD8 + T cells to play an effective role in shockandkill HIVcure strategies among slowprogressor children, because after la tency reversal, HIVspecific CD8 + T cells will be required to kill virusinfected cells expressing escape variants in both pediatric and adult infection (Deng et al., 2015) .
However, the success of an escapecornering strategy depends on the ability of the immune system to not only generate variantspecific immune responses as the virus es capes but also drive the selection of escape mutants that significantly diminish viral replicative capacity and limit fur ther escape options. The ability of the immune system to generate sequential immune responses against viral variants and yet fail to corner HIV is especially well described in the context of neutralizing antibody activity against HIV, in which the virus is always one step ahead of contempo raneous antibody (Wei et al., 2003) . Env is highly variable and sequence changes appear to have little impact on viral replicative capacity (Troyer et al., 2009) . VNC children whose HIVspecific CD8 + T cell responses are not typ ically targeting conserved epitopes in Gag and Pol may therefore lack an escapecornering facility, irrespective of their ability to generate variantspecific CTL responses. To induce such responses may require immunotherapeu tic vaccination, ideally using a mosaic insert encoding the common escape variants (Fischer et al., 2007; Barouch et al., 2010) , in those conserved epitopes (Hayton et al., 2014; Ondondo et al., 2016) . A precedent for the effectiveness of such an approach in redirecting the specificity of the CTL response toward more conserved regions of the proteome has been described in the Phambili trial of the MRKAd5 Gag/Pol/Nef T cell vaccine, in which induction of higher Gagspecific responses among HLAB*58:02positive sub jects who became HIVinfected was associated with lower viral loads than in the HLAB*58:02positive placebo con trols who later became infected . In natural HIV infection, HLAB*58:02 is associated with dominant Envspecific CD8 + T cell responses and high viral loads (Ngumbela et al., 2008) . Thus, eradication of the viral reservoir likely requires the ability of HIVspecific CD8 + T cell activity to both recognize autologous variants and oper ate effectively in killing virusinfected cells, which in part is related to specificity of the response.
The greater ability of infected children compared with adults to generate de novo variantspecific CD8 + T cell re sponses is described here in relation to the GagTL9 epitope that is immunodominant among HIVindividuals expressing HLAB*42:01 or HLAB*81:01 and some other HLA class I molecules in the B7 superfamily, such as HLAB*39:10 (Les  lie et al., 2006) . These are highly prevalent in the subSaharan African populations worst affected by the HIV epidemic, and one or more of these HLA class I molecules are expressed in approximately one third of these individuals. We previ ously described the same ability of children and not adults to only the Q182G variant, by population sequencing of virus. The mother (K-044-M) was HLA-B*42:01/81:01 negative and autologous virus when sequenced at child's age 4.5 yr encoded wild-type TL9, suggesting that wild-type TL9 was transmitted to the child. ELI SPOT assays repeated in triplicate. (C) The magnitude of the IFN-g ELI SPOT response to wild-type TL9 is lower than to the autologous variant among children (n = 11; mean 531 vs. 1,010 spot-forming cells per million PBMCs; P = 0.02, paired t test; P = 0.002, Wilcoxon signed-rank test). Among adults, the IFN-γ ELI SPOT response to wild-type TL9 tended to be higher than to the autologous TL9 variant, although this did not reach statistical significance (n = 16; median 1,597 vs, 882 spot-forming cells per million PBMCs; P = 0.25, paired t test; P = 0.40, Wilcoxon signed-rank test). (D) Frequency of subjects showing preferential recognition of autologous variant is significantly higher in pediatric subjects than adult subjects (10/11 = 91%; vs. 5/16 = 31%; P = 0.0047, Fisher's exact test). SFC, spot-forming cell. generate autologous variantspecific responses in a study of HLAB*57/58:01-restricted GagTW10 responses, where 73% of children mounted de novo variantspecific responses compared with 9% of adults (P = 0.0004; Feeney et al., 2005) . Thus, although the generation of de novo responses to variants is not unique to HIVinfected children (Allen et al., 2005) , this phenomenon appears on the basis of this and the current study to be much more common among chil dren. Caveats to this analysis, as mentioned above, include the fact that the viral sequence transmitted by the mother was not known in all cases; however, restricting the analysis to the children in whom either evolution of the variantspecific response could be shown via longitudinal analyses, or in whom maternal virus encoded wildtype GagTL9, the preferential recognition of the autologous variant remained significantly more common among children than adults (P = 0.0045). Furthermore, our finding that 5 of 16 (31%) adults had GagTL9 variant-specific responses may overes timate the number generating these responses subsequent to a wildtype-specific response, because it is likely that in a proportion of these adults, the virus transmitted encoded a GagTL9 variant. Although wildtype virus tends to be pref erentially transmitted , even when it is present at lower frequency than the escape variant, as illus trated in the current study (for example, Fig. 5 D) , as many as 18% of HLAB*42:01/81:01-negative individuals carry GagTL9 variants (Payne et al., 2014) , presumably that were selected before transmission. Why adults might be less able to mount variantspecific responses than children is unknown, but one may speculate that this difference is related to the respective numbers of naive and memory T cells in children and adults. In adults, it may be more likely that a memory CD8 + T cell response would crossreact weakly with a novel CD8 + T cell escape variant; hence, no de novo response would be initiated, giving rise to a situation akin to "original antigenic sin" (Klenerman and Zinkernagel, 1998) among adults. This phenomenon has been proposed to explain disease after dengue reinfection by a distinct subtype of virus from the virus that caused primary infection (Mongkolsapaya et al., 2003) . In VNC children, the rate of escape in env and nef is significantly greater than in pol and to lesser extent than in gag. Conversely, the opposite pattern is observed in VC children, where the rate of escape is significantly greater in gag and pol than in env and nef. (C) Difference in the rate of escaped variants accumulating in the different gene regions over time in VNC and VC children. This was estimated by calculating the difference in the slopes of the linear regression for VNC and VC children for each bootstrap replicate (n = 50). The interquartile range of this statistic is plotted to indicate that VNC children have greater accumulation of escaped variants in env and nef and lower accumulation of escaped variants in pol than VC children. There is statistically no difference in the rate of escape in gag-specific restricted CD8 + T cell epitopes. The observations made here of distinct CD8 + T cell specificities among VC and VNC children are consistent with several studies indicating that Gag and, to a lesser extent, Polspecific CD8 + T cell responses are more effective at con trolling viremia than nonGag/Pol specificities (Klein et al., 1995; Riviére et al., 1995; Ogg et al., 1998; Barouch et al., 2002 Barouch et al., , 2003 Edwards et al., 2002; Novitsky et al., 2003; Mase mola et al., 2004; Zuñiga et al., 2006; Geldmacher et al., 2007; Kiepiela et al., 2007; Sacha et al., 2007a,b; Streeck et al., 2007; Kawashima et al., 2009 Kawashima et al., , 2010 Payne et al., 2010; Goulder and Walker, 2012; Janes et al., 2013) . The mechanisms for these proteinspecific differences remain unclear but may be re lated to the ability of Gag and Pol epitopes in particular to be presented on the surface of infected cells before de novo HIV protein synthesis and concomitant HLA downregulation (Sacha et al., 2007a,b) and substantially earlier than Nef or Env specificities. However, it is evident that factors other than protein specificity, including functional avidity and polyfunc tionality (Almeida et al., 2007 (Almeida et al., , 2009 , also play an important role in the ability of a particular CD8 + T cell response to control HIV replication. Factors contributing to the differ ences in specificity of the HIVspecific CD8 + T cell responses in the VNC and VC groups of children are likely to include those shown to be important in adult infection, namely the HLA class I molecules expressed (Kiepiela et al., 2004) and the viral sequence transmitted (Goepfert et al., 2008; Carl son et al., 2016) . These factors have previously been shown also to have a strong influence on specificity of the CD8 + T cell response in infected infants (Goulder et al., 2001b; Tho bakgale et al., 2007) . The impact of transmission of a virus preadapted to HLA in the child will be especially marked, because the mother shares at least half the class I molecules expressed in the child, and in such cases, the transmitted virus may be highly preadapted (Goulder et al., 2001b; Thobakgale et al., 2007; Goepfert et al., 2008; Carlson et al., 2016) . Not withstanding these differences in the protein specificity of the CD8 + T cell response and in the viral loads of the two sub groups of PSPs studied here, these were not reflected in CD4 count differences (Fig. 1) , underlining the lack of a significant correlation typically observed between viral load and absolute CD4 count in pediatric infection (Ssewanyana et al., 2007; Muenchhoff et al., 2016) .
The observation of high rates of CD8 + T cell escape in Nef and Env in the VNC pediatric subjects is consistent with the dominant Env and Nefspecific CD8 + T cell responses detected. Previous studies in adults have shown that rate of escape is related to the magnitude of the response, its rela tive immunodominance compared with the other responses generated, and epitope entropy (Ferrari et al., 2011; Liu et al., 2013) . The rate and location of escape mutations is to a sur prisingly large degree predictable, independent of the CD8 + T cell response actually generated (Barton et al., 2016) , based on knowledge of epitopes, the transmitted viral sequence, and entropy. Although the mean entropies of Gag and Pol pro teins are substantially less than those of Env and Nef (Yusim et al., 2002) , and much of the analysis here has focused on proteinspecific CD8 + T cell responses and immune escape, it is important to note that there are also relatively conserved regions within Nef and Env and that the impact of escape mutations on viral replicative capacity may differ greatly be tween epitopes within the same protein. Indeed, the impact of an escape mutation may be vastly different, depending on which particular mutation is selected within a single epitope. This is well illustrated by the GagTL9 epitope studied here and previously ( Fig. 4 ; Wright et al., 2010 Wright et al., , 2012 Tsai et al., 2016) , in which the T186S and T186M mutants dramatically decrease viral replicative capacity, whereas mutants such as Q182S have relatively little impact.
The observation here of widespread early HIVspecific CD8 + T cell escape in pediatric infection was unexpected given previous studies that have shown a striking lack of ef ficacy of antiHIV CD8 + T cell responses in infected chil dren, even involving the same specificities that are believed to underlie HLA class I-mediated control of viremia in adult infection. For example, the HLAB*57/58:01-restricted Gag TW10 epitope (Gag residues 240-248) is one of the earliest HIVspecific CD8 + T cell responses generated in acute infec tion (Altfeld et al., 2001 (Altfeld et al., , 2006 Leslie et al., 2004; Brumme et al., 2008) and characteristically drives the selection of es cape mutants such as T242N that reduce viral replicative ca pacity (MartinezPicado et al., 2006) or, more rarely, other variants such as A248D that substantially cripple the virus (Miura et al., 2009 ). However, even though a highfrequency HLAB*57/58:01-restricted TW10 response can be ev ident at birth among in utero-infected infants, progression is observed without any selection of escape mutants, sug gesting lack of antiviral efficacy in this age group (Adland et al., 2015) . In contrast, among HLAB*57/58:01 adults with disease progression, TW10 escape is almost universal (Marti nezPicado et al., 2006) . Furthermore, the absence of HLA B*57/58:01/81:01-mediated protection against disease progression in pediatric infection, contrasting with the strong influence of these alleles in adult infection, is additional indi rect evidence that HIVspecific CD8 + T cell responses play an insignificant role in pediatric slow progression (Adland et al., 2015) . Finally, more recent data directly measuring magnitude and breadth of virusspecific CD8 + T cell activity further in dicate that these responses do not contribute significantly to progression rates in pediatric infection . Indeed, a progressively more active CD8 + T cell re sponse that is observed through childhood (Luzuriaga et al., 1995; Scott et al., 2001; Thobakgale et al., 2007) can be associ ated with higher levels of immune activation and accelerated CD4 decline in these children .
The current studies demonstrate the benefit of nextgeneration deep sequencing (NGS) compared with previous approaches involving population sequencing and/ or sequencing of limited numbers of viral clones to address the question of early escape in pediatric infection have Pillay et al., 2005; SanchezMerino et al., 2005) . Here, we have been able to demonstrate via NGS the absence of rare variants in the transmitting mother. This is important, because even if the mother does not carry the HLA allele driving selection pressure in the child, it is not uncommon for the virus that is transmitted to the mother to have come from the father of the child and hence to include variants within epitopes that are restricted by HLA only shared by the father and the child (Pillay et al., 2005) . The combination of NGS showing no variant in the transmitting mother, and 100% selection of a variant within an epitope restricted by an HLA allele only expressed in the child, as illustrated by the HLAA*74-associated variant K12N (Table 2) , is compelling evidence of early selection pressure on the virus driven by CD8 + T cell responses among these infants.
The significance of these findings for slowprogressor children who have gone onto ART as per the guidelines rec ommending universal ART for all HIVinfected children, ir respective of health of CD4 count, has been discussed above. HIVspecific CTL responses in VC children have the poten tial to make an effective contribution to eradication of viral reservoir after latency reversal, both because of the capac ity to recognize autologous variants and because the CTL specificities are generally Gag/Pol specific and effective at killing virusinfected cells. HIVspecific CTL responses in VNC children may require redirection toward these more conserved Gag/Pol specificities via immunotherapeutic im munization in order to be effective. For the HIVinfected children not studied here in whom ART was initiated early, either prophylactically to prevent immune decline or thera peutically to allow immune reconstitution, it is possible that the viral reservoir may not be comprised so extensively with escape variants because of lack of selection pressure as de scribed above. However, it is likely that immunotherapeutic immunization via a T cell vaccine inducing broad, conserved Gag/Pol specificities in these children also would increase the likelihood of HIVspecific CTL making an effective impact on the viral reservoir.
In considering how the situation might differ between HIVinfected adults and children, several factors may contrib ute. In HIVinfected adults, widespread CD8 + T cell escape typically occurs early in infection (Goulder and Walker, 1999; Brumme et al., 2008; Goonetilleke et al., 2009; Boutwell et al., 2013) , and most of the latent reservoir virus expresses escape mutants (Deng et al., 2015) . Thus, the relative inability of the adult immune system to mount autologous variantspecific CD8 + T cell responses may represent a major obstacle to ef fective clearance of the adult viral reservoir. Immune recon stitution is both more rapid and more complete in children than in adults on ART (Franco et al., 2000; Gibb et al., 2000; Douek et al., 2003; Feeney et al., 2003; Walker et al., 2004; Sabin et al., 2008) , and therefore, the immunogenicity of a T cell vaccine may be substantially greater in ARTtreated children (Swadling et al., 2016) . Immunotherapeutic vacci nation using a mosaic insert encoding the common escape variants (Fischer et al., 2007; Barouch et al., 2010) might be expected to induce responses to the autologous variants more effectively in children than in adults. In all these respects, therefore, the HIVspecific CD8 + T cell responses in infected children may be more likely than those in adults to play an effective part in eradication of the viral reservoir. If CD8 + T cell responses against "low fitness" variants can be induced ei ther naturally or via vaccination in children, the prospects for HIV "remission" after ART (Persaud et al., 2013; SáezCirión et al., 2013; Frange et al., 2016) may be greater in pediat ric than adult infection.
MAterIALs And MetHods study subjects
Eleven children studied here were from the previously de scribed Pediatric Early HAA RT and Strategic Treatment Interruption Study Thobakgale et al., 2007 Thobakgale et al., , 2009 Prendergast et al., 2008) . This feasibility study enrolled 75 HIVinfected infants born to HIVpositive mothers at St. Mary's and Prince Mshiyeni Hospitals in Kwa ZuluNatal, South Africa, in 2003 . Antenatal mothers were recruited in the third trimester of pregnancy; mothers and infants received a single dose of nevirapine at delivery (the only available regimen for prevention of motherto child transmission at the time; infant ART was not available at government hospitals). Infants were randomized to one of three study arms: deferred treatment, immediate uninter rupted treatment for 12 mo, or immediate 18mo treatment with structured interruptions Pren dergast et al., 2008) . Diagnosis of HIV infection in infants and HLA class I typing were performed as previously de scribed (Kiepiela et al., 2004; Mphatswe et al., 2007; Tho bakgale et al., 2007; Prendergast et al., 2008) . CD4 + T cell counts were determined by flow cytometry using standard clinical protocols. HIV plasma viral load measurements were done using the Roche Amplicor Monitor assay according to the manufacturer's instructions. Eleven children from this co hort were termed PSPs, defined here as children infected via mothertochild transmission who before universal ART rec ommendations for pediatric HIV infection had not met ART initiation criteria by the age of 5 yr (CD4 >350 cells/mm 3 or WHO stage III or IV; Table 1 ).
The study was approved by the Biomedical Research Ethics Committee of the University of KwaZuluNatal and the Institutional Review Boards of the Massachusetts General Hospital and the University of Oxford. The moth ers gave written informed consent for participation of their children.
Additionally, for the analysis of CD8 + T cell responses to the wildtype versus autologous variantspecific epi topes (Fig. 6) , we used PBMCs from treatmentnaive HIV C clade-infected subjects from the following previously de scribed cohorts: pediatric Kimberley cohort from Kimber ley, South Africa (Adland et al., 2015) ; adult Gateway cohort from Durban, South Africa (Payne et al., 2014) ; and adult Thames Valley Cohort from Northampton General Hospital, Northampton, UK, and Wycombe Hospital, High Wycombe, UK (Payne et al., 2010) . All were C clade-infected adults with chronic HIV infection. Among the Kimberley pediatric sub jects, the mean age at enrolment was 6.5 yr, mean CD4 count was 876 cells/mm 3 , mean CD4% was 31.4%, and median viral load was 33,000 copies/ml. Among the adults, the mean CD4 count was 531 cells/mm 3 , (IQR, 429-576 cells/mm 3 ), and the median viral load was 8,700 HIV copies/ml plasma (IQR, 5, 814) . All participants provided written informed consent. Ethics approval was given by the University of Kwa ZuluNatal Biomedical Research Board and the University of Oxford Ethics Committee.
IFn-γ eLI sPot assays
Ex vivo HIVspecific CD8 + T cell responses were screened in IFNγ ELI SPOT assays using a panel of 410 overlap ping 18mer peptides, spanning the entire HIV proteome, based on 2001 C clade consensus sequence, as described previously (Addo et al., 2003; Kiepiela et al., 2004; Tho bakgale et al., 2007) . Spots were counted using an auto mated ELI SPOT reader (AID ELI SPOT v4.0; Autoimmun Diagnostika) and manually checked. Background (>3 SDs above the mean of the 4 wells containing PBMCs without a peptide) was subtracted from values of all wells, and the final result was expressed as number of spotforming cells per 10 6 PBMC. Positive responses were considered >100 spotforming cells/10 6 PBMCs after background subtrac tion. In IFNγ ELI SPOT assays to determine recognition of wildtype TL9 and autologous GagTL9 variants, where adequate cell numbers were available, assays were performed in triplicate at peptide concentrations of 10 −10 M to 10 −4 M (Fig. 6, A and B) . In subjects where cell numbers were lim iting, peptide concentrations of 10 −6 M to 10 −4 M were used. Data shown in Fig. 6 (C and D) were determined by calculating the mean of the responses to TL9 wildtype and autologous TL9 variant peptides at concentrations of 10 −6 M to 10 −4 M for each subject.
Viral rnA extraction
Onemilliliter plasma aliquots were thawed at 37°C in a water bath and centrifuged for 1.5 h at 15,000 rpm; 860 µl supernatant was removed, and viral RNA was isolated from the remaining 140 µl using QIAmp Viral RNA Mini kit (QIA GEN) following the manufacturer's instructions. Sam ples with a viral load <2,000 copies/ml were concentrated by putting two or three aliquots of plasma (if available) through the same QIAmp column.
Population sequencing of gag
Genomic DNA was extracted from whole blood via the QIAamp DNA Blood Mini kit (QIA GEN). HIV gag se quences were amplified by nested PCR to obtain population sequences using the primers 5′CTC TAG CAG TGG CGC CCG AA3′ and 5′TCC TTT CCA CAT TTC CAA CAG CC3′ for the first round and 5′CAA TTT CTG GCT ATG TGC CC3′ and 5′ACT CGG CTT GCT GAA GTGC3′ for the second round. Viral RNA was isolated from plasma by use of a QIAamp Viral RNA Mini kit (QIA GEN). The GagPro tease region was amplified by RTPCR from plasma HIV1 RNA using Superscript III OneStep Reverse transcrip tion kit (Invitrogen) and the following Gagproteasespe cific primers: 5′CAC TGC TTA AGC CTC AAT AAA GCT TGCC3′ (HXB2 nucleotides 512-539) and 5′TTT AAC CCT GCT GGG TGT GGT ATT CCT3′ (nucleotides 2,851-2,825). Secondround PCR was performed using forward primer (5′GAC TCG GCT TGC TGA AGC GCG CAC GGC AAG AGG CGA GGG GCG ACT GGT GAG TAC GCC AAA AAT TTT GAC TAG CGG AGG CTA GAA GGA GAG AGA TGGG3′, 695-794) and reverse primer (5′GGC CCA ATT TTT GAA ATT TTT CCT TCC TTT TCC ATT TCT GTA CAA ATT TCT ACT AAT GCT TTT ATT TTT TCT GTC AAT GGC CAT TGT TTA ACT TTTG3′, 2,646-2,547). All PCR products were purified using a QIAquick PCR puri fication kit (QIA GEN) according to manufacturer's instruc tions. Sequencing was undertaken using the Big Dye Ready Reaction Terminator Mix (V3; Applied Biosystems) analyzed using Sequencher v4.8 (Gene Codes Corporation) and man ually aligned using Se_Al software.
Amplification of full-length viral rnA for ultra-deep sequencing
Amplification of the full HIV genome in four overlapping fragments was performed using SuperScript III OneStep RTPCR System with Platinum Taq High Fidelity (Invi trogen), as previously described (Gall et al., 2012) . To con firm amplification, PCR products were run on 1% agarose gel with 240 V, 300 mA for 1.5 h, and bands were visualized under UV light. Amplicons were then combined into one pool (5 µl of amplicon 1 and 10 µl each of amplicons 2, 3, and 4) and ultradeep sequenced at the Wellcome Trust Sanger Institute (Cambridge, UK).
ultra-deep sequencing and de novo assembly of viral genomes
Libraries were prepared from 50-1,000 ng DNA as described previously (Quail et al., 2008 (Quail et al., , 2011 using one of 96 mul tiplex adaptors for each pool of amplicons. Pairedend se quencing with a read length of 300 bp was performed using the Illumina MiSeq instrument as described previously (Gall et al., 2014) . Consensus sequences were generated by de novo assembly (i.e., without a reference sequence) using Iterative Virus Assembler (Hunt et al., 2015) . epitope haplotype calling from ultra-deep sequencing data Gaps in the de novo assembled genomes were filled using ma ternal or a reference sequence. The reads were then mapped to the assemblies using MOS AIK (Lee et al., 2014) with default parameters. A subtype C reference genome was an notated with the location of the epitopes of interest. The de novo assemblies were aligned using MUS CLE (Edgar, 2004) to the annotated reference to determine the location of the epitopes in each assembly. VPhaser 2 with default parameters was used to call variants (Yang et al., 2013) and VProfiler to call haplotypes (Henn et al., 2012) for the HLAassociated epitopes. Only haplotypes with greater than 1% frequency were included in the analysis.
Phylogenetic analysis of HIV genomes
HIV genomes from 11 PSP mother-child pairs were ultra deep sequenced. Maternal time points included closest to delivery, if available, and 5-7 yr after delivery, if available; children's time points included earliest available, ∼2.5, ∼5, and ∼7 yr of age or only the earliest and 5 yr of age time points (43 full genomes and seven partial genomes were generated). To confirm the close relationship between viral sequences from mother-child pairs, a maximumlikelihood phylogenetic tree was constructed using the General Time Reversible models of nucleotide substitution, from the 43 fullgenome sequences and eight cladespecific reference sequences with 1,000 bootstrap replicates in MEGA version 6.06mac software (Tamura et al., 2013) . The tree was visualized in FigTree v1.4.2 (http ://tree .bio .ed .ac .uk / software /figtree /) and Adobe Illustrator CS4 v14.0.0. HIV subtype (C) was confirmed with REGA tool, v3.0 (de Oliveira et al., 2005) .
calculating the contribution to escape in Vc and Vnc children targeting Gag-tL9
The Gene Cutter tool (http ://www .hiv .lanl .gov /content /sequence /GENE _CUT TER /cutter .html) was used to extract sequences of the nine HIV proteins from the de novo assembled consensus sequences from mother-child pairs; proteinencoding sequences were then translated in Geneious 6.1.8 and aligned in Mega6.06.
A panel of wellcharacterized epitopes (Table S4 ) across full HIV proteome restricted by the six HLAA/B/C al leles expressed among the 11 PSPs was compiled. To exam ine escape in HLArelevant CD8 + T cell epitopes, for each child, regions of the virus encoding the CD8 + T cell epitopes restricted by any of the six HLA alleles expressed by that child were analyzed. Only polymorphisms that developed independently in the child (i.e., had not been transmitted by the mother) were included and confirmed using epi tope minor variant data.
The extent of HLAdriven escape was quantified as the proportion of HLAassociated sites that were adapted to that allele (i.e., polymorphisms that are enriched in the presence of an HLA allele or polymorphisms that differ from the poly morphisms that are less frequently observed in the presence of that HLA allele) based on previously defined HLAas sociated escape sites (Carlson et al., 2012 (Carlson et al., , 2014 . The num ber of HLAassociated adaptations observed across the HIV proteome in each child was divided by the total number of HLAassociated epitopes relevant to that child's HLA reper toire (Payne et al., 2014) . calculating the rate of escape in HLA-restricted cd8 + t cell epitopes We have defined escape as a nonsynonymous mutation that has arisen in the HLArestricted CD8 + T cell epitope sequence since the founder virus, which we infer from the consensus sequence of the first time point. A panel of well characterized epitopes (Table S4 ) across full HIV proteome restricted by six HLAA/B/C alleles expressed among the 11 PSPs was compiled. To examine the accumulation of escape mutations in different gene regions, the proportion of sequences that accumulated at least one escape mutation was calculated for each time point for known restricted CD8 + T cell epitopes per patient. Furthermore, we ensured that there were at least 100 sequences with 95% coverage of the epitope region to estimate the proportion of "escaped" sequences. The mean accumulation of escaped variants per gene was obtained by fitting a linear regression model to the proportion of escaped variants over time. We also explored a logistic regression model, although the sum of squared errors and Akaike information criterion indicated that the linear regression model provided a significantly better fit to the data. The statistical uncertainty of these rates was assessed by generating 50 bootstrapped datasets for each patient. The difference in the rates of escape was estimated by calculating the difference in the slope of the linear regression model (per bootstrap replicate) between VNC and VC children for each gene. These analyses were performed using custom made python scripts (code available at https ://github .com / jnarag /DeepGenomeAnalysis).
site-directed mutagenesis of t186M
T186M mutation of HIV1 Gag sequence was introduced into SK254(M), a modified version of a patientderived sub type C HIV1 Gagprotease sequence (SK254, GenBank accession no. HM593258) with p24 Gag identical to con sensus C inserted in pNL43. The mutation was engineered by using QuikChange Lightning sitedirected mutagenesis kit (Agilent Technologies) along with customdesigned mu tagenesis forward and reversed primers: 5′CAC CCC ACA AGA TTT AAA CAT GAT GTT AAA TAC AGT GGG GGG3′ and 5′CCC CCC ACT GTA TTT AAC ATC ATG TTT AAA TCT TGT GGG GTG3′. The mutation was confirmed by sequencing after the mutagenesis.
Virus propagation
Plasmid preparation was performed according to manufac turer's instructions (HiSpeed plasmid Maxi kit; QIA GEN). To generate mutant viruses, the T186M GagPro ampli fied and purified PCR products and BstE II linearized pNL43Δgagprotease (New England Biolabs) were trans fected into the GFPreporter GXR cell line via electropo ration in a BioRad GenePulsar II using 0.4cm cuvettes at 300 V, 500 µF and infinite resistance as previously described (Miura et al., 2009) . Virus propagation was monitored by flow cytometry to detect infected GFPpositive cells. Virus culture supernatants were harvested when 30% of cells were GFPpos itive. Viruses were aliquoted and stored at −80°C until use.
statistical analysis
Statistical analyses were performed in Prism (v5.0c; GraphPad) or R (v3.3.1; The R Foundation for Statistical Computing). Linear mixed effect regression analyses were performed using the lme4 package in R, with the lmer (for continuous out comes) or glm (for binomial outcomes such as PSP group) functions, in each case we allowed for a random effect attrib utable to the age in days at which each donor was sampled, and solved for the (fixed) effect estimate caused by PSP group. When estimating the change in immune response over time (as in Fig. 2 ), we modeled age as a fixed effect and allowed for a random effect caused by donor. We calculated likelihood ratio pvalues using the ANO VA function in R to compare two nested models (i.e., a model with the predictor variable of interest versus a null model omitting only that variable) that were fit under a maximumlikelihood scenario. The pvalues reported are not adjusted for multiple comparisons. Data plots were made using the ggplot2 package, and the default span (0.75) was used for the LOW ESS smoothed lines shown in the figures. The code used for analyses is available from the authors. The response variables of interest were left untransformed in the case of the absolute CD4 count, CD4 + T cell percentage, IFNγ ELI SPOT breadth and IFNγ ELI SPOT magnitude, but the HIV viral load was modeled after log 10 transformation.
For comparisons between two groups at a single time point, or of mean measures, data were analyzed in Prism. Data were first confirmed to have parametric or nonparametric distribution (D'Agostino and Pearson om nibus normality test). For twogroup analyses t test (para metric) or Mann-Whitney U test (nonparametric) was performed; for ≥threegroup analyses ANO VA (paramet ric) or Kruskal-Wallis (nonparametric) followed by post hoc test was performed. Strength of association between two variables was analyzed by Pearson (nonparametric) or Spearman (parametric) correlation. Pvalues < 0.05 were considered significant. online supplemental material Fig. S1 shows phylogenetic tree from 43 fullgenome se quences of the 11 PSP and their mothers. Table S1 shows HLAassociated escape mutations that developed in the VNC child 517C. Table S2 shows HLAassociated escape muta tions that developed in the VNC child 021C. Table S3 shows 11 HLAB*42:01-positive and/or HLAB*81:01-positive children from Southern Africa in whom autologous virus encoded a GagTL9 variant. Table S4 lists epitopes used in the analysis of pediatric deep sequence data. Tables S1-S4 are provided as Excel files. Walker contributed to study design and reviewed the manuscript. P. Kellam and A. Gall performed some of the experiments, contributed to data analyses, and reviewed the manuscript. V. Naranbhai analyzed data and contributed to manuscript revision. P.C. Matthews designed and supervised the study, contributed to data analyses, and wrote and reviewed the manuscript. P.J.R. Goulder conceived, designed, and supervised the study, contributed to data analyses, found funding for the study, and wrote the manuscript. 
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